CervoMed Inc. (CRVO)
NASDAQ: CRVO
· Real-Time Price · USD
10.51
0.30 (2.94%)
At close: Sep 05, 2025, 3:59 PM
10.00
-4.85%
After-hours: Sep 05, 2025, 07:30 PM EDT
2.94% (1D)
Bid | 9.52 |
Market Cap | 97.25M |
Revenue (ttm) | 7.78M |
Net Income (ttm) | -22.61M |
EPS (ttm) | -2.63 |
PE Ratio (ttm) | -4 |
Forward PE | -4.89 |
Analyst | Strong Buy |
Ask | 10.7 |
Volume | 83,277 |
Avg. Volume (20D) | 357,450 |
Open | 10.26 |
Previous Close | 10.21 |
Day's Range | 9.97 - 10.74 |
52-Week Range | 1.80 - 20.63 |
Beta | -6.25 |
About CRVO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRVO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRVO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CervoMed Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-3.45%
CRVO stock has given up its prior gain. CervoMed s...
Unlock content with
Pro Subscription
1 month ago
-3.45%
CervoMed shares are trading higher after the company announced results from its Phase 2 RewinD-LB trial.